Annual report
6823.TEDINET S100OETJ
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥21.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.3bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.7bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥33.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥30.7bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥29.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥28.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.8bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.0bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥25.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.7bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.2bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥21.0bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥19.6bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.9bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥952m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥970m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥757m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥695m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥542m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥566m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥529m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥532m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥816m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥181.41 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.27 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.96 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥163.14 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥153.76 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,057.4 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,931.15 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,810.87 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,713.99 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,594.19 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.3% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.1% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 954 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 932 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 916 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 886 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 864 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥18.2bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥16.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥17.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.6bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.8bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.9bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.0bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥29.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥27.6bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥26.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.1bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥23.0bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥21.5bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥20.4bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥19.3bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥17.8bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.2bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥172.29 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.15 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.39 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.05 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥157.21 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥45 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,872.33 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,750.31 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.3 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,569.38 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,450.83 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,309,100 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,303,400 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 504 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 502 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 501 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 496 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 486 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥64m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥64m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥10.3bn |
| Environmental Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥238m |
| Environmental Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥141m |
| Environmental Equipmentreportable segment | employees | at 2022-03-31 | 149 pure |
| Environmental Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Environmental Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.7bn |
| Environmental Equipmentreportable segment | segment assets | at 2022-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥574m |
| Medical Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥501m |
| Medical Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥310m |
| Medical Equipmentreportable segment | employees | at 2022-03-31 | 559 pure |
| Medical Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥11.7bn |
| Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥11.7bn |
| Medical Equipmentreportable segment | segment assets | at 2022-03-31 | ¥10.9bn |
| Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥806m |
| Particle Countersreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥245m |
| Particle Countersreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥190m |
| Particle Countersreportable segment | employees | at 2022-03-31 | 128 pure |
| Particle Countersreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Particle Countersreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Particle Countersreportable segment | segment assets | at 2022-03-31 | ¥6.8bn |
| Particle Countersreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.7bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥984m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥641m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥22.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥22.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥22.9bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥114m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥62m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥9.2bn |
| Environmental Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥251m |
| Environmental Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥149m |
| Environmental Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| Environmental Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| Environmental Equipmentreportable segment | segment assets | at 2021-03-31 | ¥4.8bn |
| Environmental Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥476m |
| Medical Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥595m |
| Medical Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥353m |
| Medical Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥11.1bn |
| Medical Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥11.1bn |
| Medical Equipmentreportable segment | segment assets | at 2021-03-31 | ¥10.9bn |
| Medical Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥410m |
| Particle Countersreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥301m |
| Particle Countersreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥171m |
| Particle Countersreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥5.2bn |
| Particle Countersreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥5.2bn |
| Particle Countersreportable segment | segment assets | at 2021-03-31 | ¥5.8bn |
| Particle Countersreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥1.1bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥673m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥20.5bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥20.5bn |
| —segment total | segment assets | at 2021-03-31 | ¥21.4bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥2.2bn |
| Environmental Equipmentreportable segment | employees | at 2022-03-31 | 129 pure |
| Medical Equipmentreportable segment | employees | at 2022-03-31 | 235 pure |
| Particle Countersreportable segment | employees | at 2022-03-31 | 80 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,537
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of consolidated subsidiaries | CurrentYearInstant | 6 | |
| Finished goods | Prior1YearInstant | 2072957000 | JPY |
| Finished goods | CurrentYearInstant | 1775166000 | JPY |
| Work in process | Prior1YearInstant | 1056882000 | JPY |
| Work in process | CurrentYearInstant | 1198769000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 2070473000 | JPY |
| Raw materials and supplies | CurrentYearInstant | 2243834000 | JPY |
| Accumulated depreciation ppe by group | Prior1YearInstant | -12068195000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -12459645000 | JPY |
| Write downs of inventories | Prior1YearDuration | 10851000 | JPY |
| Write downs of inventories | CurrentYearDuration | 10634000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 1647413000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 1766062000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 11081416000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 4212138000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 5172604000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 20466159000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 20466159000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 11081416000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 4212138000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 5172604000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 20466159000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 20466159000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 409653000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 476216000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 1334825000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 2220695000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YearDuration | 2220695000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 10856604000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 4774984000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 5802447000 | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 21434035000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 9249735000 | JPY |
| Assets | Prior1YearInstant | 30683771000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 353000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 148667000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01842-000ParticleCountersReportableSegmentMember | 170978000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReportableSegmentsMember | 672646000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | 61674000 | JPY |
| Depreciation segment information | Prior1YearDuration | 734321000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E01842-000MedicalEquipmentReportableSegmentsMember | 9023000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |